Skip to content
10-K

Annual Report

Crinetics Pharmaceuticals, Inc. CRNX

0001658247-26-000012

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 13, 2026 104.71M sh
Shares Diluted FY 2025 · Dec 31, 2025 94.06M sh
Shares Diluted FY 2025 · Dec 31, 2024 80.78M sh
Shares Diluted FY 2025 · Dec 31, 2023 58.07M sh
Capex FY 2025 · Dec 31, 2025 $5.76M
Capex FY 2025 · Dec 31, 2024 $3.84M
Capex FY 2025 · Dec 31, 2023 $4.69M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$377.92M
Operating Cash Flow restated FY 2025 · Dec 31, 2024 −$230.19M
Operating Cash Flow restated FY 2025 · Dec 31, 2023 −$168.6M
Short Term Investments FY 2025 · Dec 31, 2025 $926.35M
Short Term Investments FY 2025 · Dec 31, 2024 $1.09B
Cash And Equivalents FY 2025 · Dec 31, 2025 $101.54M
Cash And Equivalents FY 2025 · Dec 31, 2024 $264.55M
Cash And Equivalents FY 2025 · Dec 31, 2023 $54.9M
Stockholders Equity FY 2025 · Dec 31, 2025 $992.08M
Stockholders Equity FY 2025 · Dec 31, 2024 $1.32B
Stockholders Equity FY 2025 · Dec 31, 2023 $539.11M
Stockholders Equity FY 2025 · Dec 31, 2022 $316.33M
Current Liabilities FY 2025 · Dec 31, 2025 $85.07M
Current Liabilities FY 2025 · Dec 31, 2024 $59.68M
Total Liabilities FY 2025 · Dec 31, 2025 $134.17M
Total Liabilities FY 2025 · Dec 31, 2024 $109.79M
Current Assets FY 2025 · Dec 31, 2025 $1.05B
Current Assets FY 2025 · Dec 31, 2024 $1.38B
Total Assets FY 2025 · Dec 31, 2025 $1.13B
Total Assets FY 2025 · Dec 31, 2024 $1.43B
Eps Diluted FY 2025 · Dec 31, 2025 −$4.95
Eps Diluted FY 2025 · Dec 31, 2024 −$3.69
Eps Diluted FY 2025 · Dec 31, 2023 −$3.69
Eps Basic FY 2025 · Dec 31, 2025 −$4.95
Eps Basic FY 2025 · Dec 31, 2024 −$3.69
Eps Basic FY 2025 · Dec 31, 2023 −$3.69
Sga Expense FY 2025 · Dec 31, 2025 $191.33M
Sga Expense FY 2025 · Dec 31, 2024 $99.74M
Sga Expense FY 2025 · Dec 31, 2023 $58.09M
Rd Expense FY 2025 · Dec 31, 2025 $332.06M
Rd Expense FY 2025 · Dec 31, 2024 $240.16M
Rd Expense FY 2025 · Dec 31, 2023 $168.53M
Net Income FY 2025 · Dec 31, 2025 −$465.32M
Net Income FY 2025 · Dec 31, 2024 −$298.41M
Net Income FY 2025 · Dec 31, 2023 −$214.53M
Operating Income FY 2025 · Dec 31, 2025 −$516.77M
Operating Income FY 2025 · Dec 31, 2024 −$338.85M
Operating Income FY 2025 · Dec 31, 2023 −$222.61M
Cost Of Revenue FY 2025 · Dec 31, 2025 $1.08M
Cost Of Revenue FY 2025 · Dec 31, 2024 $0
Cost Of Revenue FY 2025 · Dec 31, 2023 $0
Revenue FY 2025 · Dec 31, 2025 $7.7M
Revenue FY 2025 · Dec 31, 2024 $1.04M
Revenue FY 2025 · Dec 31, 2023 $4.01M